Search by Drug Name or NDC

    NDC 69866-1030-05 MACI 15000000; 15 1/1; cm2/1 Details

    MACI 15000000; 15 1/1; cm2/1

    MACI is a INTRA-ARTICULAR IMPLANT in the CELLULAR THERAPY category. It is labeled and distributed by Vericel Corporation. The primary component is AUTOLOGOUS CULTURED CHONDROCYTES; PORK COLLAGEN.

    Product Information

    NDC 69866-1030
    Product ID 69866-1030_fde88bef-fa85-4f86-8c0c-e4ad5668e202
    Associated GPIs 75840015209100
    GCN Sequence Number 076989
    GCN Sequence Number Description autol chrondrocy/collagen,porc SHEET 500K/CM2 IMPLANT
    HIC3 S1A
    HIC3 Description JOINT TISSUE REPLACEMENT
    GCN 42853
    HICL Sequence Number 044023
    HICL Sequence Number Description AUTOLOGOUS CULTURED CHONDROCYTES/COLLAGEN, PORCINE
    Brand/Generic Brand
    Proprietary Name MACI
    Proprietary Name Suffix n/a
    Non-Proprietary Name autologous cultured chondrocytes
    Product Type CELLULAR THERAPY
    Dosage Form IMPLANT
    Route INTRA-ARTICULAR
    Active Ingredient Strength 15000000; 15
    Active Ingredient Units 1/1; cm2/1
    Substance Name AUTOLOGOUS CULTURED CHONDROCYTES; PORK COLLAGEN
    Labeler Name Vericel Corporation
    Pharmaceutical Class Autologous Cultured Cell [EPC], Cells, Cultured, Autologous [EXT], Chondrocytes [CS]
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA125603
    Listing Certified Through 2024-12-31

    Package

    NDC 69866-1030-05 (69866103005)

    NDC Package Code 69866-1030-5
    Billing NDC 69866103005
    Package 1 BAG in 1 BOX (69866-1030-5) / 1 BOTTLE, PLASTIC in 1 BAG (69866-1030-4) / 1 IMPLANT in 1 BOTTLE, PLASTIC (69866-1030-3)
    Marketing Start Date 2017-06-09
    NDC Exclude Flag N
    Pricing Information N/A